Summary of S&P 500 and some of the stock I'm invested in
This is my first video on TradingView, where I’m sharing insights on my current trades, how they're performing, and some key lessons from recent mistakes that I need to address moving forward.
Quick Summary:
S&P 500 is starting to look overextended, increasing the likelihood of a pullback.
This isn’t the ideal time to jump into new trades. Instead, I’m waiting for a pullback to the 10 EMA, which could offer better entry opportunities.
Exelixis (EXEL) turned out to be a fantastic trade, with a strong move upward.
After such momentum, it's wise to expect a pullback. I'm letting the stock breathe, with the goal of possibly catching the next leg up.
I also reviewed a few other trades and highlighted some stocks that are on my watchlist.
Right now, I’m letting the market unfold naturally and looking for clear setups before entering again.
Trading is a game of patience and positioning—it's not about forcing trades, but about waiting for the right ones.
Quick Summary:
S&P 500 is starting to look overextended, increasing the likelihood of a pullback.
This isn’t the ideal time to jump into new trades. Instead, I’m waiting for a pullback to the 10 EMA, which could offer better entry opportunities.
Exelixis (EXEL) turned out to be a fantastic trade, with a strong move upward.
After such momentum, it's wise to expect a pullback. I'm letting the stock breathe, with the goal of possibly catching the next leg up.
I also reviewed a few other trades and highlighted some stocks that are on my watchlist.
Right now, I’m letting the market unfold naturally and looking for clear setups before entering again.
Trading is a game of patience and positioning—it's not about forcing trades, but about waiting for the right ones.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.